Cannara Biotech Inc. (TSXV:LOVE)
Canada · Delayed Price · Currency is CAD 1.720
-0.030 (-1.71%)
At close: Feb 2, 2026
Cannara Biotech Revenue
Cannara Biotech had revenue of 30.11M CAD in the quarter ending November 30, 2025, with 20.11% growth. This brings the company's revenue in the last twelve months to 112.36M, up 28.06% year-over-year. In the fiscal year ending August 31, 2025, Cannara Biotech had annual revenue of 107.32M with 30.64% growth.
Revenue (ttm)
112.36M
Revenue Growth
+28.06%
P/S Ratio
1.47
Revenue / Employee
248.33K
Employees
452
Market Cap
164.75M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2025 | 107.32M | 25.17M | 30.64% |
| Aug 31, 2024 | 82.15M | 24.59M | 42.71% |
| Aug 31, 2023 | 57.56M | 21.57M | 59.91% |
| Aug 31, 2022 | 36.00M | 18.73M | 108.48% |
| Aug 31, 2021 | 17.27M | 15.17M | 723.42% |
| Aug 31, 2019 | 2.10M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ascend Wellness Holdings | 718.79M |
| TerrAscend | 417.11M |
| Aurora Cannabis | 367.13M |
| Organigram Global | 259.18M |
| Auxly Cannabis Group | 146.00M |
| Medexus Pharmaceuticals | 145.00M |
| HLS Therapeutics | 77.79M |
| Charlotte's Web Holdings | 68.58M |